Nebenwirkungen · Tobi Podhaler
TOBI Podhaler 28 mg inhalation powder, hard capsules · Abschnitt 4.8 · PDF-Seite 7
HOS-124620 · Präparat HOS-095897
Adverse drug reactions in Table 1 are listed according to system organ classes in MedDRA. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention (CIOMS III): very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-11T16:59:00Z · SHA-256 7ea3d369534b07b678f44c73bb09b66b38c9e5d6fad7bb29248bd93c9bd47738 · Passage a191e746a18fd92780b44d3cd390919169fe1fba51471e568561e0adeb911822 · Zeichen 783–1420 im Abschnitt